Vetoquinol SA (EPA:VETO)
France · Delayed Price · Currency is EUR 78.40
+0.10 (0.13%)
Apr 2, 2026, 5:35 PM CET
Vetoquinol Revenue
In the year 2025, Vetoquinol had annual revenue of 525.70M EUR, down -2.50%. Vetoquinol had revenue of 257.63M in the half year ending June 30, 2025, with 0.54% growth.
Revenue
525.70M
Revenue Growth
-2.50%
P/S Ratio
1.76
Revenue / Employee
210.53K
Employees
2,497
Market Cap
924.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 525.70M | -13.50M | -2.50% |
| Dec 31, 2024 | 539.20M | 9.93M | 1.88% |
| Dec 31, 2023 | 529.27M | -10.51M | -1.95% |
| Dec 31, 2022 | 539.78M | 18.51M | 3.55% |
| Dec 31, 2021 | 521.27M | 93.81M | 21.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| Ramsay Générale de Santé | 5.32B |
| Clariane SE | 5.31B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.97B |
| Equasens Société anonyme | 224.73M |
| Nanobiotix | 32.59M |